In the era of antibiotic resistance, when more and more bacteria are becoming insensitive to conventional drugs, bacteriophages are regaining their place at the forefront of medicine. These microscopic bacteria hunters —natural viruses that attack bacterial cells with incredible precision—are no longer just objects of scientific research. Today, they are becoming the basis for entire therapeutic strategies. But how does an organism invisible under a microscope transform into a ready-made phage preparation , available in pharmacies?

It's a complex, multi-stage process that combines biotechnology, microbiology, pharmacology, and even logistics. This article will examine the phage's entire journey—from initial isolation in the laboratory to the moment it reaches a patient in a vial.

Step one: bacteriophage isolation

The creation of any phage preparation begins with the search for a "wild" phage. The most common sources are wastewater, soil, food industry waste, or even patient biomaterial. There, in the natural environment, bacterial viruses are constantly on the hunt for their hosts.

Microbiologists isolate samples, then mix them with a culture of a specific bacterial pathogen (for example, staphylococcus or E. coli) and observe whether lysis zones appear—that is, areas where the bacteria are destroyed. This is a sign of an active bacteriophage .

It is then "caught," purified, and studied morphologically and genetically. One of the key criteria is high specificity and safety . It is important that the phage does not carry toxins or antibiotic resistance genes and does not exhibit lysogenic activity (that is, it cannot integrate into bacterial DNA without destroying it).

Growing, Purifying, and Testing: How a Phage Becomes a "Drug"

Once a candidate phage is deemed promising, the mass cultivation stage begins. This is done using fermenters—specialized devices in which the phage infects bacteria, replicates within them, and is released into the environment. The process typically takes 6–12 hours.

After replication, the phage suspension must be purified. Bacterial cell debris, toxins, proteins, and lipopolysaccharides are removed. This is achieved by filtration, centrifugation, ultrafiltration, and sometimes chromatography.

At this stage, it is also important to determine the titer—the number of active phage particles in the preparation. The higher the titer, the more effective the phage product will be. Simultaneously, tests are conducted to ensure sterility, the absence of impurities, and biological activity.

Formation of phage cocktails

Most often, pharmacies offer not a single phage but a phage cocktail —a mixture of several bacteriophages targeting different pathogens or variants of the same bacterial species. This increases effectiveness and reduces the risk of resistance.

Such cocktails can be broad-spectrum (for example, against enterobacteria, staphylococci, and streptococci) or targeted. In the latter case, they are individually prepared based on the patient's bacterial culture results—this is personalized phage therapy .

The mixtures are tested for compatibility: it's important that the phages don't inhibit each other. Only after effectiveness is confirmed does the cocktail move on to the next stage.

Adding stabilizers and preparing the dosage form

To ensure a good virus retains its activity in a preparation, it must be properly stabilized. This can include buffer solutions, isotonic media, gelatin, or glycerol. In some cases, freezing or lyophilization is used (to stabilize phages, but this is not always a standard procedure; its use depends on the specific preparation and its intended use).

The prepared suspension is poured into vials, ampoules, capsules, or added to gels, ointments, or suppositories, depending on the intended use. The expiration date, storage conditions, phage titer, spectrum of activity, and route of administration are always indicated.

Registration and quality control: official recognition of the drug

For a phage preparation to be available in pharmacies, it must be registered with health authorities. This procedure varies from country to country, but the principles are similar: documentation of the production process, confirmation of safety, and laboratory and clinical testing results.

Ukraine has several officially registered phage agents , which are manufactured according to strict standards. A system for the approval of individual-use drugs is also in place, where the phage is selected specifically for the patient's condition.

Monitoring of such drugs is carried out not only at the production stage, but also afterward – through monitoring of effectiveness, side effects, and feedback from doctors.

Logistics and Storage: The Finish Line

Proper transportation and storage are equally important. Many bacterial viruses are sensitive to temperature, ultraviolet light, and pH fluctuations. Therefore, phage preparations are stored refrigerated or at a stable temperature, and the packaging protects them from light.

Distribution is carried out through pharmacy chains, hospitals, or individually if the drug is manufactured to order. It is important that the phage remains active at every stage—from the laboratory to the patient—otherwise, the treatment will be ineffective.

How bacteriophages reach the patient: clinical applications

Once the drug reaches the doctor, the most crucial stage begins— the actual use of the bacteriophage in treatment . After diagnosis and (preferably) microbiological confirmation of the pathogen, the doctor prescribes a phage solution. If a personalized match is available, laboratory specialists perform sensitivity testing and formulate a customized cocktail.

Phages can be prescribed in the presence of:

• intestinal infections;

• diseases of the genitourinary system;

• purulent wounds and burns;

• respiratory tract infections;

• postoperative complications;

• sepsis when antibiotics do not help.

The duration of the course depends on the location of the infection, the patient's response, and their overall condition. Phage therapy is generally well-tolerated, causes no side effects, and can be combined with other medications.

Outlook: What's Next?

In the future, bacteriophage production will become even more innovative. The use of bioengineering, the creation of synthetic phages, and automated testing of patient microbiota are all already underway at research centers in Europe, the United States, and Ukraine.

Particular attention will be paid to the creation of phage banks —centralized phage repositories ready for rapid use. This will enable responses to epidemics and changes in antibiotic resistance, ensuring precise and effective therapy in the shortest possible time.

It is also possible to introduce bacteriophages into veterinary medicine, agriculture, and the food industry as biological means of controlling bacteria that are safe for the environment and human health.

From the first contact between a phage and a bacterium in a Petri dish to the moment a drug saves a person, a long and precise process takes place. This isn't magic—it's biotechnological science, in which every step is crucial. And while many challenges remain, phage preparations are already demonstrating enormous potential and deserve their rightful place in pharmacies and treatment protocols.